Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEAUVIA Hydro Deluxe is a biodegradable, non-cross-linked hyaluronic acid (HA) hydrogel enriched with 0.01% calcium hydroxyapatite (CaHA) and the amino acids glycine and L-proline. Developed and manufactured by Matex Lab, it is designed for deep biorevitalization and improvement of skin quality, specifically targeting dehydration, loss of elasticity, and superficial wrinkles in the face, neck, décolletage, and hands. The hyaluronic acid is derived from *Bacillus subtilis*, and the addition of CaHA is intended to stimulate fibroblast activity and endogenous collagen production. It is classified as a Class III medical device under EU MDR 2017/745 regulation and is typically administered via intradermal injection (mesotherapy).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NEAUVIA Hydro Deluxe.